Search
Search Results
##search.searchResults.foundPlural##
-
ON THE VERSATILITY OF VON WILLEBRAND FACTOR
2750PDF: 1093HTML: 11207 -
VON WILLEBRAND FACTOR, ANGIODYSPLASIA AND ANGIOGENESIS
3678PDF: 1530HTML: 8009Randi Fig: 163 -
EFFECTS OF FACTOR XIII DEFICIENCY ON THROMBOELASTOGRAPHY. THROMBELASTOGRAPHY WITH CALCIUM AND LYSIS BY ADDITION OF STREPTOKINASE IS MORE SENSITIVE THAN SOLUBILITY TESTS
3104PDF: 940HTML: 1882Untitled: 153Untitled: 158Untitled: 153Untitled: 155Untitled: 148 -
CIRCUMCISION IN MALES WITH BLEEDING DISORDERS
1865PDF: 872HTML: 6751Cover letter: 151 -
HIV-ASSOCIATED VENOUS THROMBOEMBOLISM
3803PDF: 1436HTML: 8493 -
DYNAMIC MONITORING OF ADAMTS 13 ACTIVITY FOR DIFFERENTIAL DIAGNOSIS ACROSS THE SPECTRUM OF SEPSIS ASSOCIATED WITH THROMBOTIC MICROANGIOPATIES Adamts 13 and Sepsis Associated with Thrombotic Thrombocytopenic Purpura
574PDF: 387HTML: 76 -
THE PROTHROMBOTIC STATE ASSOCIATED WITH SARS-COV-2 INFECTION: PATHOPHYSIOLOGICAL ASPECTS COVID and Thrombosis
1896PDF: 777HTML: 206 -
Guest Editor: G. Castaman GENE THERAPY FOR HEMOPHILIA: FACTS AND QUANDARIES IN THE 21ST CENTURY GENE THERAPY FOR HEMOPHILIA
1984PDF: 1833HTML: 332 -
MILD BLEEDERS: DIAGNOSIS IS ELUSIVE IN LARGE NUMBER OF PATIENTS
3280PDF: 702HTML: 702Figure 1 Distribution of the various causes of mild bleeding (in %) in males and females: 168Figure 2 Age and Sex distribution of patients with Bleeding disorders- Unclassified: 163Table : Distribution of the sites of bleeding and their causes: 169 -
-
SARS-CoV-2 INFECTED PATIENTS: FROM A HEMATOLOGIST PERSPECTIVE COVID-19 and Hematology
1003PDF: 939HTML: 306 -
MOLECULAR MECHANISMS OF INHIBITOR DEVELOPMENT IN HEMOPHILIA Guest Editor: Giancarlo Costaman
3083PDF: 1580HTML: 398 -
PATHOGENESIS AND TREATMENT OF THROMBOHEMORRHAGIC DIATHESIS IN ACUTE PROMYELOCYTIC LEUKEMIA
1761PDF: 785HTML: 10211Figures 1,2,3: 157 -
VASCULAR ENDOTHELIAL GROWTH FACTOR IN CHILDREN WITH THALASSEMIA MAJOR PDF
1255PDF: 834HTML: 1023Figure 1 the correlation between frequency of blood transfusion and serum vascular endothelial growth factor (VEGF).: 159 -
MUTATIONAL PROFILES OF F8 AND F9 IN A COHORT OF HAEMOPHILIA A AND HAEMOPHILIA B PATIENTS IN THE MULTI-ETHNIC MALAYSIAN POPULATION
1978PDF: 1031HTML: 679Figure 1: 138Figure 2: 153 -
FAMILIAL MEDITERRANEAN FEVER AND HYPERCOAGULABILITY
1163PDF: 691HTML: 1208 -
TOXICITIES ASSOCIATED WITH CAR-T CELL THERAPIES CAR-T Cell Toxicity
1968PDF: 1390HTML: 248 -
PATHOGENESIS OF MALARIA IN TISSUES AND BLOOD
4370PDF: 1878HTML: 17712 -
NEW THERAPEUTIC OPTIONS FOR THE TREATMENT OF SICKLE CELL DISEASE Guest Editor: Raffaella Origa
6720PDF: 3586HTML: 731 -
Idiopathic pulmonary embolism in a case of severe family ANKRD26 thrombocytopenia
2102PDF: 809HTML: 914Patient’s family tree: 154 -
THALASSEMIA AND VENOUS THROMBOEMBOLISM
2880PDF: 990HTML: 4564 -
Refractory Immune Thrombocytopenic Purpura and Cytomegalovirus Infection: A Call for a Change in the Current Guidelines
4179PDF: 1143HTML: 2128Figure 1: 152 -
COAGULOPATHY IN BETA-THALASSEMIA: CURRENT UNDERSTANDING AND FUTURE PERSPECTIVES
1045PDF: 472HTML: 8137 -
Microangiopathic Anemia of Acute Brucellosis – is it a True TTP?
1137PDF: 772HTML: 1759
1 - 48 of 48 items







